Form 4 ARDELYX, INC. For: Feb 20 Filed by: Williams Laura A
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Ardelyx, Inc (ARDX) PT Raised to $13 at H.C. Wainwright
February 23, 2024 6:08 AM ESTH.C. Wainwright analyst Ed Arce raised the price target on Ardelyx, Inc (NASDAQ: ARDX) to $13.00 (from $11.00) while maintaining a Buy rating.
The analyst comments "We project U.S. IBSRELA annual net sales growth of 84% in 2024. Yesterday, Ardelyx announced 2023 U.S. IBSRELA net sales for irritable bowel syndrome (IBS-C) of $80.1M, largely in-line with... More
